viernes, 31 de mayo de 2019

Congress wants a single ALS patient to get a therapy never tested in humans

Congress wants a single ALS patient to get a therapy never tested in humans

The Readout

Damian Garde

More reads

  • When ‘right to try’ isn’t enough: Congress wants an ALS patient to get a therapy never tested in humans. (STAT)
  • Chinese pharma company Hansoh aims for $1 billion IPO. (Financial Times)

No hay comentarios: